+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology Reagents - Global Strategic Business Report

  • PDF Icon

    Report

  • 232 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338910
The global market for Biotechnology Reagents is estimated at US$99.3 Billion in 2023 and is projected to reach US$135.1 Billion by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Technological innovations within the sector are critical in driving the biotechnology reagents market forward, with developments in fluorescence-based assays, high-throughput screening technologies, and the production of biopharmaceuticals necessitating advanced reagents that offer higher sensitivity and specificity. The expansion of the diagnostics sector, spurred by the COVID-19 pandemic and the increasing prevalence of chronic diseases, further underscores the need for precise diagnostic reagents. Additionally, the growing trend of collaborations between academic and commercial entities to expedite the commercialization of research is enhancing the demand for sophisticated biotechnology reagents, supporting the dynamic growth of this market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Chromatography Technology segment, which is expected to reach US$40.6 Billion by 2030 with a CAGR of a 3.5%. The In-vitro Diagnostics Technology segment is also set to grow at 3.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $26.8 Billion in 2023, and China, forecasted to grow at an impressive 7.4% CAGR to reach $28.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Biotechnology Reagents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biotechnology Reagents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Biotechnology Reagents Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Molecular, Inc., Agilent Technologies, Inc., BD Biosciences, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 267 Featured):

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Biotechnology Reagents - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Investments in Life Sciences Research Propels Growth in Biotechnology Reagents Market
  • Technological Advancements Drive Adoption of Next-Generation Sequencing Reagents
  • Increasing Focus on Personalized Medicine Expands Addressable Market Opportunity
  • Innovations in CRISPR and Gene Editing Technologies Accelerate Demand for Specialized Reagents
  • Growing Use of Stem Cells Spurs Market Growth for Advanced Reagents
  • Focus on Regenerative Medicine Throws the Spotlight on Tissue Engineering Reagents
  • Expansion of Biotechnology Industry Generates Demand for High-Quality Reagents
  • Rising Prevalence of Chronic Diseases Fuel Demand for Diagnostic Reagents
  • Development of Synthetic and Animal-Free Reagents Strengthens Business Case for Ethical Research
  • Shift towards Automation in Laboratories Expands Addressable Market Opportunity
  • Focus on High-Throughput Screening Technologies Drives Adoption of Automated Reagents
  • Growing Popularity of Organoid Research Impacts Market Dynamics
  • Rising Awareness of Cell Therapy Applications Generates Demand for Advanced Reagents
  • Integration of AI and Machine Learning Throws the Spotlight on Predictive Reagents Models
  • Adoption of Advanced Imaging Techniques Strengthens Business Case for High-Resolution Reagents
  • Focus on Reducing Contamination Risk Generates Demand for Sterile Reagents
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Biotechnology Reagents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for In-vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: Canada Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: Canada 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
JAPAN
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 26: Japan Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Japan Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Japan 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
CHINA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 29: China Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: China Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: China 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
EUROPE
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 32: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Europe 16-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 35: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Europe 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
FRANCE
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 38: France Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: France Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: France 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
GERMANY
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 41: Germany Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: Germany Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Germany 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
ITALY
  • Table 44: Italy Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Italy Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Italy 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 47: UK Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: UK Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: UK 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
SPAIN
  • Table 50: Spain Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Spain Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Spain 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
RUSSIA
  • Table 53: Russia Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Russia Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Russia 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 56: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Rest of Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Rest of Europe 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 60: Asia-Pacific Historic Review for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Asia-Pacific 16-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Asia-Pacific Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Asia-Pacific 16-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2014, 2024 & 2030
AUSTRALIA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

Table Information